- Home
- WTTR vs STOK Comparison
WTTR vs STOK Comparison
Compare WTTR & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTTR
- STOK
- Stock Information
- Founded
- WTTR 2016
- STOK 2014
- Country
- WTTR United States
- STOK United States
- Employees
- WTTR N/A
- STOK N/A
- Industry
- WTTR Oilfield Services/Equipment
- STOK Biotechnology: Pharmaceutical Preparations
- Sector
- WTTR Energy
- STOK Health Care
- Exchange
- WTTR Nasdaq
- STOK Nasdaq
- Market Cap
- WTTR 1.1B
- STOK 1.3B
- IPO Year
- WTTR 2017
- STOK 2019
- Fundamental
- Price
- WTTR $10.10
- STOK $35.22
- Analyst Decision
- WTTR Strong Buy
- STOK Strong Buy
- Analyst Count
- WTTR 3
- STOK 7
- Target Price
- WTTR $15.00
- STOK $30.83
- AVG Volume (30 Days)
- WTTR 1.2M
- STOK 1.3M
- Earning Date
- WTTR 11-04-2025
- STOK 11-04-2025
- Dividend Yield
- WTTR 2.75%
- STOK N/A
- EPS Growth
- WTTR N/A
- STOK N/A
- EPS
- WTTR 0.32
- STOK 0.91
- Revenue
- WTTR $1,458,995,000.00
- STOK $199,893,000.00
- Revenue This Year
- WTTR N/A
- STOK $416.54
- Revenue Next Year
- WTTR N/A
- STOK N/A
- P/E Ratio
- WTTR $31.62
- STOK $38.48
- Revenue Growth
- WTTR N/A
- STOK 1218.82
- 52 Week Low
- WTTR $7.20
- STOK $5.35
- 52 Week High
- WTTR $15.14
- STOK $35.04
- Technical
- Relative Strength Index (RSI)
- WTTR 55.13
- STOK 88.52
- Support Level
- WTTR $9.89
- STOK $29.62
- Resistance Level
- WTTR $10.72
- STOK $32.40
- Average True Range (ATR)
- WTTR 0.33
- STOK 1.96
- MACD
- WTTR -0.12
- STOK 0.78
- Stochastic Oscillator
- WTTR 34.60
- STOK 97.83
About WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure and Chemical Technologies. It generates the majority of its revenue from Water Services segment.
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.